Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-17

Clinical Trial Update: Paroxetine Versus Placebo for Vasomotor Symptom Management in Surgical Menopause [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing paroxetine to placebo for vasomotor symptoms in women with surgical menopause has completed, according to the ClinicalTrial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Paroxetine (Paroxetine hydrochloride)

Snippet

Sponsor: Universidad Nacional Autonoma de Honduras | Conditions: Menopause Syndrome, Menopause Surgical | Phase 2 | Status: COMPLETED